Eczema is not contagious, and is a chronic disease that causes symptoms of dry, itchy skin that can appear like a red rash, with some patients reporting a burning sensation, tingling or stinging.

After a couple of days filled with investor nervousness, Arcutis Biotherapeutics has claimed FDA approval of Zoryve for the new indication of atopic dermatitis (AD), a common form of eczema.

Q4 2024 Earnings Call Transcript January 31, 2025 AbbVie Inc. misses on earnings expectations. Reported EPS is $2.16 EPS, ...

AbbVie (NYSE:ABBV – Get Free Report) issued an update on its FY 2025 earnings guidance on Friday morning. The company ...

AbbVie (NYSE:ABBV – Get Free Report) announced its earnings results on Friday. The company reported $2.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ...